Janowitz T, Gablenz E, Pattinson D, Wang T, Conigliaro J, Tracey K
Gut. 2020; 69(9):1592-1597.
PMID: 32499303
PMC: 7299656.
DOI: 10.1136/gutjnl-2020-321852.
Imai Y, Inada M, Tamura S, Kawata S, Minami Y, Tarui S
Br J Clin Pharmacol. 1986; 22(4):495-6.
PMID: 3490271
PMC: 1401159.
DOI: 10.1111/j.1365-2125.1986.tb02925.x.
Krishna D, Klotz U
Clin Pharmacokinet. 1988; 15(4):205-15.
PMID: 2903807
DOI: 10.2165/00003088-198815040-00001.
Testa R, Grasso A, Dagnino F, Ibba R, Varagona G, Celle G
Br J Clin Pharmacol. 1987; 23(6):779-80.
PMID: 2886146
PMC: 1386177.
Penston J, Wormsley K
Med Toxicol. 1986; 1(3):192-216.
PMID: 2878343
DOI: 10.1007/BF03259837.
Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
Clissold S
Drugs. 1986; 32(3):197-221.
PMID: 2875864
DOI: 10.2165/00003495-198632030-00001.
Effect of famotidine on oxidative drug metabolism.
Somerville K, Kitchingman G, Langman M
Eur J Clin Pharmacol. 1986; 30(3):279-81.
PMID: 2874031
DOI: 10.1007/BF00541528.
Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide.
Klotz U, Arvela P, Rosenkranz B
Eur J Clin Pharmacol. 1985; 28(6):671-5.
PMID: 2866097
DOI: 10.1007/BF00607913.
Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.
Langtry H, Grant S, Goa K
Drugs. 1989; 38(4):551-90.
PMID: 2573505
DOI: 10.2165/00003495-198938040-00005.
Randomized, double-blind comparison of famotidine with ranitidine in treatment of acute, benign gastric ulcer disease. Community-based study coupled with a patient registry.
Brazer S, TYOR M, Pancotto F, Brice R, Garbutt Jr J, Wildermann N
Dig Dis Sci. 1989; 34(7):1047-52.
PMID: 2568247
DOI: 10.1007/BF01536372.
A comparison of the influence of famotidine and cimetidine on phenytoin elimination and hepatic blood flow.
Sambol N, Upton R, CHREMOS A, Lin E, Williams R
Br J Clin Pharmacol. 1989; 27(1):83-7.
PMID: 2565119
PMC: 1379708.
DOI: 10.1111/j.1365-2125.1989.tb05338.x.
Clinical pharmacokinetics of famotidine.
Echizen H, Ishizaki T
Clin Pharmacokinet. 1991; 21(3):178-94.
PMID: 1764869
DOI: 10.2165/00003088-199121030-00003.
